Pharmacovigilance and methods Flashcards

(38 cards)

1
Q

What is the definition of adverse drug reactions (ADRs)?

A

ADRs are harmful or unintended responses to medications that can lead to significant health issues and may be preventable.

ADRs remain a leading cause of death in some countries and impose a high financial burden on healthcare systems.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is pharmacovigilance?

A

Pharmacovigilance is the systematic and science-based approach to monitoring and assessing the safety of drugs.

The term is derived from the Greek words ‘pharmakon’ (drug) and ‘vigilare’ (to keep watch).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How does the WHO define pharmacovigilance?

A

The WHO defines pharmacovigilance as the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug/vaccine related problems.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the two phases of the pharmacovigilance framework?

A
  • Pre-Marketing Surveillance
  • Post-Marketing Surveillance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the focus of post-marketing surveillance?

A

Post-marketing surveillance focuses on ADRs reported after a drug is approved and marketed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is passive surveillance in pharmacovigilance?

A

Passive surveillance involves spontaneous reports from healthcare professionals or patients regarding ADRs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is active surveillance in pharmacovigilance?

A

Active surveillance is targeted monitoring for specific events or medications to discover the number of ADRs or events.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What tragic event led to improvements in pharmaceutical regulations?

A

The Sulphanilamide Elixir incident in 1937, which caused poisoning in children, led to improved pharmaceutical regulations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What was the consequence of the Thalidomide Tragedy in 1961?

A

It sparked global pharmacovigilance system development and led to the establishment of spontaneous reporting systems.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the primary objective of pharmacovigilance systems?

A

To improve patient care and well-being through safe medication use.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the three main groups involved in pharmacovigilance activities?

A
  • Regulatory
  • Industry
  • Academia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are descriptive studies in post-marketing studies?

A

Descriptive studies generate hypotheses and attempt to describe the occurrence of events related to drug toxicity and efficacy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the purpose of spontaneous reporting systems (SRS)?

A

To collect post-marketing safety data on drugs and facilitate early detection of new, rare, and serious ADRs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

True or False: Over 94% of ADRs remain unreported.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is signal detection in pharmacovigilance?

A

Signal detection is a critical process for identifying potential safety concerns related to pharmaceutical products.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are Proportional Reporting Ratios (PRRs)?

A

PRRs are a method used to compare the frequency of a specific side effect reported for one drug against all other drugs.

17
Q

What is the Bayesian Confidence Propagation Neural Network (BCPNN)?

A

BCPNN uses Bayesian statistical methods to highlight dependencies in datasets and identify unexpectedly strong relationships in ADR combinations.

18
Q

What is the Multi-Item Gamma Poisson Shrinker (MGPS)?

A

MGPS is a tool used by the FDA to look for patterns in reports about side effects or problems caused by medications.

19
Q

What are the limitations of data mining in pharmacovigilance?

A
  • Cannot differentiate between known and new associations
  • Does not consider clinical information
  • Requires manual review by experts
20
Q

What is intensive monitoring in pharmacovigilance?

A

Intensive monitoring is a form of active surveillance that collects adverse event reports from prescribers using prescription data.

21
Q

What are the strengths of intensive monitoring?

A
  • Captures real-world data
  • Detects unsuspected ADRs
  • Enables risk quantification for specific ADRs
22
Q

What is the General Practice Research Database (GPRD)?

A

A UK-based database that collects data from General Practitioners (GPs) covering approximately 3 million patients annually.

23
Q

What type of data does the GPRD collect?

A
  • Demographics
  • Medical diagnoses
  • Prescription details
  • Vaccinations
  • Lab results
24
Q

What is the percentage of focus on disease epidemiology?

25
What are the key areas of study in pharmacology mentioned?
Drug utilization, pharmacoeconomics, environmental hazards
26
How many peer-reviewed journal publications has the author contributed to?
Over 250
27
What is the PHARMO Record Linkage System?
A system developed in the Netherlands to link community pharmacy and hospital data
28
When was the PHARMO Record Linkage System developed?
In the early 1990s
29
What key demographic information does the PHARMO system use to link data?
Patient birth date, gender, and GP code
30
How many people does the PHARMO Record Linkage System cover?
Approximately 2 million
31
Since when has longitudinal data collection been ongoing in the PHARMO system?
Since 1987
32
What types of records are collected in the PHARMO Record Linkage System?
Drug-dispensing records, hospital discharge records
33
What additional data is linked to the PHARMO system?
Primary care data, population surveys, lab/genetic data, cancer/accident registries, mortality data, economic outcomes
34
What is one advantage of the PHARMO Record Linkage System?
Well-defined denominator information for incidence/prevalence estimates
35
Why is the PHARMO Record Linkage System considered cost-effective?
It uses existing databases
36
What are some uses of the PHARMO Record Linkage System?
Follow-up studies, case-control studies, analytical epidemiological studies
37
What types of effects does the PHARMO system evaluate?
Drug-induced effects, drug utilization, treatment persistence, economic impact, adverse drug reactions (ADRs)
38
Fill in the blank: The PHARMO Record Linkage System links community pharmacy and hospital data using _______.
patient birth date, gender, and GP code